Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Atossa Genetics Inc. (ATOS) had Non-Operating Income/Expense of $0.70M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.72M |
|
-- |
|
-- |
|
$7.41M |
|
$-7.41M |
|
|
Non-Operating Income/Expense |
$0.70M |
$-6.72M |
|
$-6.72M |
|
$-6.72M |
|
$-6.72M |
|
$-6.72M |
|
$-6.72M |
|
$-7.41M |
|
$-7.41M |
|
129.17M |
|
129.17M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$68.74M |
|
-- |
|
$2.00M |
|
$70.75M |
|
$5.42M |
|
-- |
|
-- |
|
$5.42M |
|
$65.32M |
|
$65.32M |
|
$65.32M |
|
129.17M |
|
| Cash Flow Statement Financials | |
$-5.96M |
|
$-0.01M |
|
-- |
|
$71.19M |
|
$65.23M |
|
$-5.97M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.28% |
|
-10.28% |
|
-9.50% |
|
-10.28% |
|
$0.51 |
|
$-0.05 |
|
$-0.05 |
|